Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
This piece reviews index funds that pair well with Roth IRA rollovers, emphasizing broad market exposure and cost efficiency for easier long-term growth.
24,239 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Europe confronts a rocket shortage leaves europe that threatens space infrastructure, defense planning, and private i...
Microsoft faces a high-growth, high-capex path as AI investment accelerates. Here is a fresh take on whether to buy, ...
A veteran Southern California luxury team is switching brokerages, moving to Sotheby’s International Realty – Monteci...
Bahrain's Economic Development Board launches a bold investment drive to attract capital amid headwinds, signaling a ...
Rising electricity costs driven by AI data centers are reshaping the landscape for utility stocks. This deep dive exp...
The House advances a sweeping housing bill described as the first major housing since the 1990s, signaling a national...
US AI labs push frontier research, but startups are embracing cheaper Chinese models to manage costs. The shift signa...
Oracle stock down 60% from its peak doesn’t tell the whole story. This article digs into the AI cloud momentum fuelin...
The high-stakes world of luxury real estate can turn on a dime. In the case of jennifer lopez’s $50m mansion, escrow ...
Warren Buffett resurfaces on CNBC as Berkshire Hathaway shares retreat, highlighting leadership transition questions ...
A strong quarter from TSMC is more than a one-off beat. This analysis explains why tsmc's revenue grew last and how c...